Citius Oncology, Inc (CTOR)
NCM · Common · CUSIP 17331Y109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CTOR and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
17331Y109
Business: Citius Oncology, Inc is a biopharmaceutical company focused on developing and commercializing innovative targeted oncology therapies Citius Oncology, Inc. is a majority-owned publicly-traded subsidiary of Citius Pharmaceuticals, Inc

Company Contact

CEO
Leonard Mazur
CFO
Jaime Bartushak
Headquarters
11 Commerce Drive, First Floor, Cranford, NJ 07016
Phone
908-967-6677
Investor Relations
info@citiusonc.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »